LSE - Delayed Quote GBp

Spire Healthcare Group plc (SPI.L)

191.20
-2.20
(-1.14%)
At close: May 23 at 4:35:28 PM GMT+1
Loading Chart for SPI.L
  • Previous Close 193.40
  • Open 188.80
  • Bid 190.60 x --
  • Ask 191.00 x --
  • Day's Range 188.80 - 194.60
  • 52 Week Range 168.20 - 263.00
  • Volume 1,260,059
  • Avg. Volume 1,042,466
  • Market Cap (intraday) 816.814M
  • Beta (5Y Monthly) 0.63
  • PE Ratio (TTM) 31.87
  • EPS (TTM) 0.06
  • Earnings Date Mar 6, 2025
  • Forward Dividend & Yield 0.02 (1.20%)
  • Ex-Dividend Date May 22, 2025
  • 1y Target Est 284.00

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics in the United Kingdom. The company operates in three segments: Hospitals Business, Vita Health Group, and The Doctors Clinic Group. It provides diagnostics, inpatient, day case, and outpatient care in areas, including orthopedics, gynaecology, cardiology, neurology, oncology, and general surgery; and primary care needs of outpatients, such as GP services, occupational health services, and mental and physical health services. The company also offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments. In addition, it provides eye surgery and treatments, family planning, gastroenterology, general medicine, haematology, hand surgery, hip and knee treatment, and heart and kidney treatments. Further, the company offers treatments in the areas of men's health, neurosurgery and neurology, paediatrics, pain management, rehabilitation, sports, physiotherapy, podiatry, respiratory medicine, and rheumatology; and scans and investigations, skin treatments, spinal surgery and treatments, sports science, urology, vascular surgery, weight loss, and women's health. Additionally, it provides treatments in the areas of back surgery, breast enlargement, cataract removal surgery, gastric bypass surgery, and prostate surgery; and offers various tests and scans, which include cardiac CT, CT, MRI, ultrasound, and X-ray scans. Spire Healthcare Group plc was founded in 2007 and is headquartered in London, the United Kingdom.

www.spirehealthcare.com

15,703

Full Time Employees

December 31

Fiscal Year Ends

Recent News: SPI.L

View More

Performance Overview: SPI.L

Trailing total returns as of 5/23/2025, which may include dividends or other distributions. Benchmark is FTSE 100 (^FTSE) .

YTD Return

SPI.L
15.39%
FTSE 100 (^FTSE)
6.67%

1-Year Return

SPI.L
25.16%
FTSE 100 (^FTSE)
4.54%

3-Year Return

SPI.L
11.87%
FTSE 100 (^FTSE)
16.03%

5-Year Return

SPI.L
98.38%
FTSE 100 (^FTSE)
45.46%

Compare To: SPI.L

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: SPI.L

View More

Valuation Measures

Annual
As of 5/23/2025
  • Market Cap

    769.33M

  • Enterprise Value

    2.01B

  • Trailing P/E

    30.84

  • Forward P/E

    20.00

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.52

  • Price/Book (mrq)

    1.03

  • Enterprise Value/Revenue

    1.33

  • Enterprise Value/EBITDA

    8.06

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    1.68%

  • Return on Assets (ttm)

    3.89%

  • Return on Equity (ttm)

    3.50%

  • Revenue (ttm)

    1.51B

  • Net Income Avi to Common (ttm)

    25.4M

  • Diluted EPS (ttm)

    0.06

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    43.7M

  • Total Debt/Equity (mrq)

    171.52%

  • Levered Free Cash Flow (ttm)

    40.83M

Research Analysis: SPI.L

View More

Company Insights: SPI.L

Research Reports: SPI.L

View More

People Also Watch